Dr. Kim K. Maale is a Plano, Texas based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Kim K. Maale is H2548 for Ophthalmology in Texas. Dr. Kim K. Maale is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Kim K. Maale speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Female
Practice Address:
3108 Midway Rd, Suite106, Plano, Texas, 75093-6383
Phone:
972-608-0359
Fax:
972-608-0605
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1598718389
NPI Enumeration Date:
19 May, 2006
NPI Last Update On:
15 Apr, 2013
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Kim K. Maale are as mentioned below.
License Number
Specialization
State
Status
H2548
Ophthalmology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3108 Midway Rd, Suite106 Plano, Texas
Zip:
75093-6383
Phone Number:
972-608-0359
Fax Number:
972-608-0605
Patients can reach Dr. Kim K. Maale at 3108 Midway Rd, Suite106, Plano, Texas or can call to book an appointment on 972-608-0359. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.